Phibro Animal Health reported $70.75M in Cash and Equivalent for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Align Technology ALGN:US $ 877.5M 48.62M
Ani Pharmaceuticals ANIP:US $ 63.38M 13.53M
Aurora Cannabis Inc ACB:CN 429.89M 97.49M
Bristol Myers Squibb BMY:US $ 10750M 1619M
Canopy Growth Corp WEED:CN C$ 769.5M 464.17M
Corcept Therapeutics CORT:US $ 35.35M 26.52M
Depomed DEPO:US $ 52.26M 9.12M
Eli Lilly And LLY:US $ 2622.9M 163.7M
Endo International Ordinary Shares ENDP:US $ 1191.57M 221.58M
Henry Schein HSIC:US $ 108M 18M
Idexx Laboratories IDXX:US $ 114.36M 90.26M
Knight Therapeutics Inc GUD:CN C$ 9.8M 5.19M
Lannett LCI:US $ 106.11M 7.47M
Nektar Therapeutics NKTR:US $ 77.54M 9.55M
Pacira Pharmaceuticals PCRX:US $ 122.06M 104.69M
Phibro Animal Health PAHC:US $ 70.75M 7.36M
Prestige Brands PBH:US $ 35.87M 8.68M
Supernus Pharmaceuticals SUPN:US $ 173.43M 57.71M
Teva Pharmaceutical Industries TEVA:US $ 2058M 117M
Zoetis ZTS:US $ 2648M 484M